1. The Research Progress on the Prognostic Value of the Common Hematological Parameters in Peripheral Venous Blood in Breast Cancer


    Li Chen et al, 2020, OncoTargets and Therapy CrossRef
  2. Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer
    Ayumu Mitsuyoshi et al, 2024, International Journal of Clinical Oncology CrossRef
  3. Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis
    Xue Qi et al, 2023, BMJ Open CrossRef
  4. A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment
    Wei Zhang et al, 2020, Frontiers in Immunology CrossRef
  5. Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis
    Lorenzo Gerratana et al, 2020, Scientific Reports CrossRef